Skip to main content
ORMP logo
ORMP
(NASDAQ)
Oramed Pharmaceuticals Inc.
$4.17-- (--)
Loading... - Market loading

Oramed Pharmaceuticals (ORMP) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

Oramed Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Oramed Pharmaceuticals Inc. (ORMP) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2012
Period EndingDec 2025Dec 2024Dec 2023Sep 2023Dec 2022Aug 2021Aug 2020Aug 2019Aug 2018Aug 2017Aug 2012
Current Assets
Cash and Cash Equivalents45.9554.429.069.0640.4677.2519.303.335.003.974.43
Short-Term Investments84.5887.51152.99152.99115.2616.9020.6028.9525.4716.150.65
Cash & Short-Term Investments130.53141.93162.05162.05155.7294.1439.9032.2830.4620.125.09
Accounts Receivable4.640.000.000.000.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.000.000.000.000.00
Other Current Assets2.741.290.540.541.391.200.611.040.570.162.32
Total Current Assets133.27143.22162.58162.58157.1195.3440.5133.3231.0420.305.28
Non-Current Assets
Property, Plant & Equipment (Net)1.341.111.571.571.800.930.170.020.020.020.00
Long-Term Investments96.2110.9156.3756.372.706.693.931.3016.3318.380.00
Other Non-Current Assets0.050.030.030.030.0225.040.020.020.020.020.01
Total Non-Current Assets97.5912.0657.9757.974.5332.664.121.3416.3618.420.00
Total Assets230.86155.28220.55220.55161.64128.0044.6334.6647.4038.715.29
Current Liabilities
Accounts Payable6.850.791.930.552.182.610.591.341.140.570.64
Short-Term Debt0.290.2251.0151.280.250.130.040.000.000.000.00
Accrued Liabilities2.471.481.380.001.981.200.000.000.000.000.00
Deferred Revenue1.350.000.000.001.342.702.702.702.452.450.00
Other Current Liabilities10.602.550.001.38-0.190.040.60-0.07-0.171.570.00
Total Current Liabilities19.095.6953.2153.215.756.684.545.314.555.170.64
Non-Current Liabilities
Long-Term Debt0.540.160.340.340.650.400.03-5.63-7.820.020.00
Deferred Tax Liabilities7.910.000.010.000.010.010.010.010.010.010.00
Other Non-Current Liabilities11.490.094.100.100.060.140.235.928.150.440.87
Total Non-Current Liabilities12.034.254.444.444.744.807.229.9611.7314.310.87
Total Liabilities31.129.9357.6657.6610.4911.4811.7515.2716.2919.471.52
Stockholders' Equity
Common Stock0.470.480.490.490.480.420.280.210.210.160.08
Retained Earnings-123.44-176.62-157.56-157.56-163.08-114.85-92.61-81.10-69.22-56.50-17.89
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.000.000.700.400.00
Additional Paid-in Capital322.71322.40320.89320.89314.42230.20125.21100.2999.4375.170.00
Minority Interest0.00-0.92-0.93-0.93-0.660.740.000.000.000.000.00
Shares Outstanding39.2839.9240.340.0039.5635.290.000.000.000.000.00
Total Stockholders' Equity199.74146.27162.89163.82151.81116.5232.8819.3931.1119.243.78
Total Liabilities & Equity230.86155.28220.55220.55161.64128.0044.6334.6647.4038.710.00

Frequently Asked Questions About Oramed Pharmaceuticals Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is ORMP's debt level?

Review Oramed Pharmaceuticals's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.